ArticleResearch square2026
[11C]CS1P1 PET links T-cell-associated immune activation with endothelial and astrocytic responses.
Tammie Benzinger, Savannah Tiemann Powles, David Hoagey, Shaney Flores, Karl Friedrichsen, Shuang Wu, Jayashree Rajamanickam, Nelly Joseph-Mathurin, Sarah Keefe, Sydney Nagy and 20 more
Abstract readPreprint
In one paragraphArticle in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
30 authors.
David HoageyWashington University in St. Louis School of Medicine.
Shaney FloresWashington University in St. Louis.
Karl FriedrichsenWashington University in St. Louis School of Medicine.
Shuang WuWashington University in St. Louis School of Medicine.
Jayashree RajamanickamWashington University in St. Louis School of Medicine.
Sarah KeefeWashington University School of Medicine - in St. Louis.
Sydney NagyWashington University in St. Louis School of Medicine.
Edita SabaredzovicWashington University in St. Louis School of Medicine.
Ashlee SimmonsWashington University in St. Louis School of Medicine.
Lynne JonesWashington University in St. Louis School of Medicine.
Anil Kumar SodaWashington University in St. Louis School of Medicine.
Jonathan PowlesWashington University in St. Louis.
Nayid JanaWashington University in St. Louis School of Medicine.
Bryce BakerWashington University in St. Louis School of Medicine.
Laura IbanezWashington University in St. Louis.
John MorrisWashington University School of Medicine.
Hongyu AnWashington University in St. Louis.
Zhude TuWashington University in St. Louis School of Medicine.
Matthew BrierWashington University in St. Louis School of Medicine.
Funding
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5MThe natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5MResearch Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7MWashington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0MTraining/DisseminationP41EB025815 · NIBIB · WASHINGTON UNIVERSITY · PI Robert J. Gropler · 2018 to 2026
$12.7MPET SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1PR1) RADIOTRACERS FOR MULTIPLE SCLEROSISR01NS103988 · NINDS · WASHINGTON UNIVERSITY · PI Tammie Lee Smith Benzinger, Zhude Tu · 2017 to 2026
$5.3MPET PROBES FOR IMAGING THE VESICULAR ACETYLCHOLINE TRANSPORTERR01NS075527 · NINDS · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2011 to 2021
$4.9MPET Imaging of Neuroinflammation in Genetic Alzheimer's DiseaseR01AG052550 · NIA · WASHINGTON UNIVERSITY · PI Beau M Ances, Tammie Lee Smith Benzinger · 2018 to 2026
$4.2MMR measured regional hypoxia as an early biomarker in cerebral small vessel diseaseRF1NS116565 · NINDS · WASHINGTON UNIVERSITY · PI AN, HONGYU, FORD, ANDRIA LEE · 2020 to 2020
$3.4MNeuroscience Training Program at Washington UniversityT32NS121881 · NINDS · WASHINGTON UNIVERSITY · PI Martha W Bagnall, Daniel Kerschensteiner · 2021 to 2026
$3.1MInvestigate neuroinflammation in the brain of PD using S1P1 radioligandsR01NS134586 · NINDS · WASHINGTON UNIVERSITY · PI JOEL Synes PERLMUTTER, Zhude Tu · 2024 to 2026
$1.8MNeuroinflammation in Cerebral Small Vessel Disease using PET/MR ImagingR21NS127425 · NINDS · WASHINGTON UNIVERSITY · PI AN, HONGYU · 2022 to 2022
$431kNCATS NIH HHS KL2 TR002346NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS R01 AG052550NIBIB NIH HHS P41 EB025815NINDS NIH HHS R01 NS075527NINDS NIH HHS R01 NS103988NINDS NIH HHS R01 NS134586NINDS NIH HHS R21 NS127425NINDS NIH HHS RF1 NS116565NINDS NIH HHS T32 NS121881
6 · The paper itselfAbstract
Neuroimmune signaling across the peripheral-vascular-glial axis is increasingly recognized as a driver of both age-related brain vulnerability and the earliest stages of neurodegenerative disease, including Alzheimer disease. Evaluating this axis in vivo remains challenging due to limited neuroinflammatory imaging biomarkers. We utilized [11C]CS1P1 positron emission tomography (PET) to quantify sphingosine-1-phosphate receptor 1 (S1PR1) availability alongside plasma proteomics in 42 cognitively normal individuals (age 21-82). Through differential abundance analysis and structural equation modeling (SEM), we identified a multi-compartment neuroimmune cascade linking peripheral T-cell activation (CD40LG), vascular endothelial disruption (ICAM1/TEK), central S1PR1 upregulation, and reactive astrogliosis (GFAP). Mediation analysis estimated this S1PR1 axis accounts for 25.5% of the total effect of CD40LG on GFAP. This cascade appears coupled to the astrocytic immune response and is exacerbated by underlying amyloid-beta pathology. These findings suggest [11C]CS1P1 may serve as an in vivo tool for evaluating peripheral-to-central immune crosstalk.
Identifiers
PMID42040951
PMCPMC13105134
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390